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THE purpose of this paper is to give a discussion of the role of genes in the
physiology leading to the development of mammary gland tumours in mice, and
to emphasize the relationship of the genes to the extrachromosomal factors in
deter
i i the probability that the individual willdevelop a mammary tumour.
Development of the inbred line-s with their characteristic tumour incidences
together with hybridization studies have provided proof that genetic factors are
influential in determining these incidences. Such incidences are expressions of
theprobabilities that females oftherespectivelines willhave a mammary tumour.
This probability may be extremely low in certain cases, such as in females of
strain C57 black in which the incidence is less than I per cent, medium in other
cases and extremely high in such mice as the females of strain C3H, with an
incidence of approximately 95 per cent.
It has been shown that aside from the genetic constitution, hormones and
the milk agent are influential in controlling the probability that the tumour will
appear. These cannot be considered as unrelated factors, but are normally interrelated in the physiology of the individual preceding the formation of the
tumour.
Inregardto the genetic influence, a mouse inh'erits a certaincomplexof genes whose actions manifest through certain physiologic paths affect the probability that a tumour will appear (Heston, 1946). One of these paths is through the
physiology of hormone production, a second is through the physiology of the
propagation and transmission of the milk agent, and a third possible path is
through the physiology within the mammary tissue cell governing its reaction
to the hormonal stimulation or the milk agent. Other paths may exist, and it
is probable that these three are interwoven.
Proof of the effect of genic action in relation to the hormonal stimulation
resultedfrom crosses between strain A in which the incidence in thevirgin females
is lowalthougb that of the breeders is high, and strain CH, inwhich the incidence
in the virgin females as well as the breeders ishigh. Results of such crosses were
reported by Bittner, H'useby, Visscber, Ball and Smith (1944), Heston and
Andervont (I944), and Bittner and Huseby (I946). The fact that a high
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incidence occurred among the virgin F, females resulting from mating strain A
females to' CH males as well as in the reciprocal F, virgins, together with
evidence of segregation in the F2 generation, indicated that the difference
betweenthe strains wasprimarily agenetic difference.
Such a difference was to be regarded as either a difference in horinone meta-
bolism, or a difference in the reaction of the mammary gland cell to horinone
stimulation. Such evidence as the fact that added oestrogen stimulationyielded
tumours 'M' strain A virgins, 'and the relationship of number of litters to tumour
incidence in strain A reported by Jones (1940), strongly indicated a difference
in hormone stimulation. Studies ofthe oestrus cycles ofvirgin females of strains
A and CH and their reciprocal F, hybrids reported by Deringer, Heston and
Andervont (1945), however, failed to show any difference in the cycles, except
that in the low-tumout group ofvirgin strain A females the onset of oestrus was
later than in the high-tubiour groups. These observations, therefore, suggested
that at least a part of the genetic difference could be manifested through the
physiology within the mammary gland cell.
In an attempt to determine the physiological mechanisms through which the
genetic differences are manifest, Huseby and Bittner (1947) also have carried out
a number ofstudies,including ovariantransplantation toF,hybrid mice, ovariec-
tomy, vaginalsmearing, andhistologic examinationofthe genital tissues. These
studies have indicated that more than 'one endocrine organis affected.
We have become more interested in the second path of gene action-that
concemed with the propagation and transmission of the milk agent. It has
been observed by a number ofinvestigators that certain strains will propagate
the agent, whereas others will not. All the. high-mammary tumour strains
normally transmit the agent fromgeneration to generation, and even low-tumour
strains may have the same innate capacity as Andervont (1945) has reported for
strain C. The introduction of the agent transforms strain C into a high tumour
strain. In Andervont's experience, however, strain C.7 black does not have this
capacity. WhileC.7 blackfemales that had nursed upon strainC3Hfemalescould
transmit the agent to susceptible young,their later generation C57 black offspring
could not. On the other hand, Bittner (1948) has found tumours in his descen-
dants of strainC57 black females into which the agent was introduced, and Fekete
and Little (1942) bave reported mammary tumours in descendants OfC,,7 black
females that had developed in strain dba uteri from transferred ova. Thus the
situat'lon mregard to the capacities ofthe various strains to propagate the agent
is not clear.
By crossing high-tumour strain C,H females with low tumour strainC57 black
males, and comparing the two. types of backeross females produced by back-
crossmg the F, females to both the CH and C.7black males, definite evidence of
genetic differences in the ability to propagate and transmit the agent was
revealed (Heston, Deringer andAndervont, 1945). A significantlyhigher tumour
incidence was observed in the high-tumour strain backcross females (CHBC)
than in the low-tumour strain backcross (BBC), although both groups had been
bom from comparable F, mothers and had received comparable milk agent.
Furthermore, the CHBC females could transmit the agent better than the BBC
females, as shown by tumour development in uniform test females fostered upon
both types of the backcross females. Since other factors were controlled, this
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to the genetic differences of the backeross females produced by the differences in
their fathers.
Individual variation in the ability to transmit the agent was particularly
apparent in the BBC females. There was not all or none expression, however,
but the variation was expressed in degreee suggesting the effect of several genes.
An important field of gene-extrachromosomal agent relationship has thus
been opened, and is being extensively investigated at the present time. The
possibility of an intracellular origin of the agent also enters into consideration.
In somerespects the picture is comparable to thegene-kapparelationship stuclied
by Sonneborn (1945) and co-workers in paramecium. The picture is not as
,simple, however, in that there is.only a single gene associated with kappa.
It is emphasized again that these differences are expressed as differences in
the probability that the. tumour will occur. Changes in' the genetic constitution
mayresult in achange inthisprobability. Variations in the hormone stimulation
result in variation in this probability. We recently have been obtaining results
indicating that the effects ofremoving the milk agen\likewise must be considered
as merely lowering the probability that a tumour will arise. Our attention has
been directed toward tumours that arise in females in which the agent cannot be
demonstrated (Heston, Deringer and Levillain, unpublished data).
In orderto obtain alineof strainCHfriae ofthe milkagent alitter of3 females
and 3 males wereremovedfrom theirC3H motherbyCesarean sectionandfostered
uponC57 black female. These females were later mated to their malelittermates,
and subsequently the line has been maintained by brother x sister matings, the
young being nursed upon their own mothers. In this line; designated as C3Hb,
mammary tumours are arising. In 194 of the females of this line 14 months of
age and older and extending through the first 5 generations to date, 47, or 24 per
cent, have developed mammary tumours at an average age of 18-9 months;
seventy-eight have died without mammary tumours at an average age of 16
months, and 69 are stillliving at an average age of 18 months.
Study of the histologic section of 37 ofthese tumours has not revealed mucli
dissimilarity between these and the usual CH mammary tumours. Nine, how-
ever,' have show-n areas of squamous metaplasia with pearl formation similar
to that described by Kirschbaum, Williams and Bittner (1946) in mammary
tumours induced by methylcholanthrene in the absence ofthe milk agent Such
areas alsooccasionally occur in normal strain CH females of older age, suggesting
that the occurrence of squamous areas may be characteristic of older age rather
than specifically owing to the possible absence of the milk agent. Three of the
tumours arising in these C3Hb females have been transplanted into other C3Hb
females, and in each case the transplant has grown.
We have noevidence,however, of amilkagentintheetiology ofthese tumours.
Distribution of the tumour-bearing females in the pedigree chart does not show
segregation of tumour families, as 'would be expected if the agent were present.
Furthermore, we have found no evidence oftheagent in cell-free extracts ofthese
tumours. These extracts variedfrom 2 to 5 percent,and werepreparedin0-005 m
.phosphate buffer pH 7-0 with a Waring blendor; cleared in a multispeed centri-
fuge at 18,000 g..for 3 minutes; and filtered through a Berkfeld H or an 8 lb.
Mandler filter. To test for theagent 0-I c.c. ofthe filtrate has beeninjecte'd into
C,Hb females at from I to 5 days of age. Many of these test females are not
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months of age and older, and none has yet developed a tumour. Extracts pre-
pared with the same technique from tumours from C3H females produce tumours
in C3Hb test females in approximately 8 to 10 months.
This is not presented as absolute proof that the agent is not present. If it
is, however, it is not comparable to that in C3H females, nor is there any evidence
of its being built up comparable to that of C3H. If the agent is not present we
have proof that the accumulation of genetic factors and of non-genetic factors
other than the milk agent can cause the tumour threshold to be surpassed. In
this light the milk agent would be comparable to the carcinogens in the induction
oflung tumours, where the presence ofthe carcinogen appears to merely increase
theprobabilitythatthetumourwillappearandatanearlierage (Heston, 1942a,b).
While all of these factors have been shown to alter the probability that the
normal mammary tissue cell may be transformed into a malignant cell, these
investigations have not answered the question as to what constitutes this change
to malignancy. To a geneticist the probability aspect of the picture and the
manner in which the probability can be altered at once suggests a mutation.
Recent advances in genetics suggest that this may not necessarily be a gene
mutation, but may be a mutation of cytoplasmic factors. Since the change is
normally irreversible, it must be a change in the fundamental physiology of the
cell. It is gratifying that the way has been opened for obtaining experimental
evidence bearing on this point, some of which will be reported later in this
symposium.
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